Biopharma companies priced four IPOs Thursday, the most for any single day since last June, raising a combined total of $303.9 million. When adding in Trevi Therapeutics Inc.'s $55 million IPO on Tuesday, the week's debuts represent a quarter of all those completed on U.S. exchanges this year, and about 18% of the total money raised.